Press release
Pancreatic Cancer Market Set to Surge Amid Breakthrough Therapies and Rising Global Demand by 2033 | Leading key players - Myriad Genetics Inc., Pfizer Inc., Novartis AG.
Pancreatic Cancer Market
The Pancreatic Cancer Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product offerings, pricing strategies, financials, growth plans, and geographic footprint.
Unlock exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/pancreatic-cancer-market?sz
The Pancreatic Cancer Market encompasses the diagnosis, treatment, and management solutions for pancreatic malignancies, including surgery, chemotherapy, radiation, and targeted therapies. It includes pharmaceutical drugs, diagnostic imaging, biomarkers, and supportive care services. Driven by rising incidence rates, technological advancements, and increasing R&D investment, the market is expanding globally, with a focus on early detection and improved patient outcomes.
Prominent Industry players in the Pancreatic Cancer Market
The prominent players in Pancreatic Cancer market research report are: Myriad Genetics Inc., Pfizer Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Amgen Inc., Viatris Inc., Boston Scientific Corporation, Clovis Oncology, and GlaxoSmithKline among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Industry News:
In October 2022, Erasca extended its existing collaboration with Pfizer to evaluate the combination of ERAS-007 and Ibrance® (palbociclib) under a clinical trial collaboration and supply agreement. The expanded partnership aims to conduct clinical proof-of-concept studies testing the combination therapy in patients with colorectal cancer harboring NRAS or KRAS mutations, as well as in those with pancreatic ductal adenocarcinoma with KRAS mutations.
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/pancreatic-cancer-market
Market Segments
By Treatment Type: Targeted Therapies, Chemotherapy, Surgery, Other Treatments.
By End-user: Hospitals, Specialty Clinics, Home care, Others.
The Pancreatic Cancer industry is undergoing swift expansion, fueled by breakthroughs in medical technology, growing demand for cutting-edge therapies, and an increasing emphasis on patient-centric care. As the sector advances, in-depth market analysis is essential to track evolving trends, regulatory developments, and new opportunities.
Regions Covered:
The global Pancreatic Cancer Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
FAQs:
✒ What is driving the growth of the Pancreatic Cancer Market?
✒ Who are the prominent players in the Pancreatic Cancer Market?
✒ How is the regulatory landscape affecting the Pancreatic Cancer Market?
✒ What regions are expected to see the highest growth?
✒ What are the key challenges faced by the Pancreatic Cancer Market?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Looking for Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=pancreatic-cancer-market?sz
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreatic Cancer Market Set to Surge Amid Breakthrough Therapies and Rising Global Demand by 2033 | Leading key players - Myriad Genetics Inc., Pfizer Inc., Novartis AG. here
News-ID: 4082801 • Views: …
More Releases from DataM Intelligence 4Market Research
Breakthroughs and Rising Investments Drive Ovarian Cancer Market Growth in 2025 …
The Global Ovarian Cancer Market reached US$ 1.8 billion in 2022 and is expected to reach US$ 8.2 billion by 2031 growing with a CAGR of 23.7% during the forecast period 2024-2031.
The Ovarian Cancer Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product…
Global Lung Cancer Treatment Market Expected to Reach USD 73.29 Billion by 2033 …
The Global Lung Cancer Treatment Market size reached US$ 32.64 billion in 2024 and is expected to reach US$ 73.29 billion by 2033, growing at a CAGR of 9.5% during the forecast period 2025-2033.
The Lung Cancer Treatment Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading…
Breakthroughs and Demand Surge: Prostate Cancer Treatment Market Set for Robust …
The Prostate Cancer Treatment Market size reached US$ 13.22 billion in 2024 and is expected to reach US$ 28.10 billion by 2033, growing at a CAGR of 7.8% during the forecast period 2025-2033.
The Prostate Cancer Treatment Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies,…
Content Intelligence Market Set to Soar: AI-Powered Insights Revolutionizing Dig …
The Global Content Intelligence Market reached US$ 852.5 million in 2022 and is expected to reach US$ 6037.7 million by 2030, growing with a CAGR of 27.7% during the forecast period 2024-2031.
The Content Intelligence Market, as examined by DataM Intelligence, provides a thorough industry overview enriched with detailed insights, historical data, and essential statistics. The report extensively explores market dynamics and competitive landscapes, featuring profiles of leading companies, their product…
More Releases for Pancreatic
Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of…
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025
Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025
Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025
Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Pancreatic Market to Insight By 2025: Top Key Vendors
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
Pancreatic Cancer Pipeline Review H1 2019
Pancreatic Cancer - Pipeline Review, H1 2017
Summary
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and…
Pancreatic Cancer Drug Pipeline Analysis
“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023.
Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,…
